Health effects from stratospheric ozone depletion and interactions with climate change

Photochemical and Photobiological Sciences

Volumn 2, Issue 1, 2003, Pages 16-28

  De Gruijl, Frank R ^a   Longstreth, Janice ^b   Norval, Mary ^c   Cullen, Anthony P ^d   Slaper, Harry ^e   Kripke, Margaret L ^f   Takizawa, Yukio ^g   Van Der Leun, Jarv C ^h  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute for Global Risk Research   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF WATERLOO   (Canada)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^f UNIVERSITY OF TEXAS   (United States)

^g National Institute for Minamata Diseases   (Japan)

^h ECORYS Netherlands   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; BASAL CELL CARCINOMA; CATARACT; CLIMATE CHANGE; HUMAN; INFECTION; NONHUMAN; OZONE LAYER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STRATOSPHERE; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; VACCINATION; DNA REPAIR; LENS; PUBLIC HEALTH; RADIATION EXPOSURE; REVIEW; SUNBURN;

ANIMALIA;

OZONE;

CATARACT; DNA REPAIR; HUMANS; LENS, CRYSTALLINE; OZONE; PUBLIC HEALTH; SUNBURN; ULTRAVIOLET RAYS;

EID: 0037258718     PISSN: 1474905X     EISSN: 14749092     Source Type: Journal    
DOI: 10.1039/b211156j     Document Type: Article

References (136)

1. J. C. van der Leun, M. Tevini, X. Tang and R. C. Worrest. Environmental Effects of Ozone Depletion; 1998 assessment, United Nations Environment Programme, Nairobi, 1998, p. 192.
2. J. Longstreth, F. R. de Gruijl, M. L. Kripke, S. Abseck, F. Arnold, H. I. Slaper, G. Velders, Y. Takizawa and J. C. van der Leim, Health risks, J. Photochem. Photobiol. B, 1998, 46, 20-39.
3. R. L. McKenzie, L. O. Bjorn, A. Bais and M. Ilyas, Changes in Biologically active ultraviolet radiation reaching the Earth's surface, Photochem. Photobiol. Sci., 2003, this issue (DOI:10.1039/b21155c).
4. D. H. Sliney, Geometrical assessment of ocular exposure to environmental UV radiation-implications for ophthalmic epidemiology, J. Epidemiol., 1999, 9, S22-32.
5. J. A. Van Best, J. L. Van Delft and J. E. Keunen, Long term follow-up of lenticular autofluorescence and transmittance in healthy volunteers, Exp. Eye. Res., 1998, 66, 117-123.
6. H. Sasaki, O. Hockwin, T. Kasuga, K. Nagai, Y. Sakamoto and K. Sasaki, An index for human lens transparency related to age and lens layer: comparison between normal volunteers and diabetic patients with still clear lenses, Ophthalmic Res., 1999, 31, 93-103.
7. S. Fu, R. Dean, M. Southan and R. Truscott, The hydroxyl radical in lens nuclear cataractogenesis, J. Biol. Chem., 1998, 273, 28603-28609.
8. Y. Berry and R. J. Truscott, The presence of a human UV filter within the lens represents an oxidative stress, Exp. Eye. Res., 2001, 72, 411-421.
9. J. W. Eaton, UV-mediated cataractoncnesis: a radical perspective, Doc. Ophthalmol., 1994, 88, 233-242.
10. J. Dillon, UV-B as a pro-aging and pro-cataract factor, Doc. Ophthalmol., 1994, 88, 339-344.
11. K. W. Lee, N. Meyer and B. J. Ortwerth, Chromatographic comparison of the UVA sensitizers present in brunescent cataracts and in calf lens proteins ascorbylated in vitro, Exp. Eve. Res., 1999, 69, 375-384.
12. H. R. Taylor, Epidemiology of age-related cataract, Eye, 1999, 13, 445-448.
13. L. C. Hayashi, N. Tamiya and E. Yano, Correlation between UVB irradiation and the proportion of cataract-an epidemiological study based on a nationwide patient survey in Japan, Ind. Health, 1998, 36, 354-360.
14. H. R. Taylor, S. K. West, F. S. Rosenthal, B. Munoz, H. S. Newland, H. Abbey and E. A. Emmett, Effect of ultraviolet radiation on cataract formation, N. Engl. J. Med., 1988, 319, 1429-1433.
15. F. Hollows and D. Moran, Cataract-the ultraviolet risk factor, Lancet, 1981, 2, 1249-1250.
16. R. Hiller, R. D. Sperduto and F. Ederer, Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey, Am. J. Epidemiol., 1983, 118, 239-249.
17. C. A. McCarty, B. N. Mukesh, C. L. Fu and H. R. Taylor, The epidemiolocy of cataract in Australia, Am. J. Opthalmol., 1999, 128, 446-465.
18. K. Sasaki, H. Sasaki, M. Kojima, Y. B. Shui, O. Hockwin, F. Jonasson, H. M. Cheng, M. Ono and N. Katoh, Epidemiological studies on UV-related cataract in climatically different countries, J. Epidemiol., 1999, 9, S33-38.
19. S. K. West, D. D. Duncan, B. Munoz, G. S. Rubin, L. P. Fried, K. Bandeen-Roche and O. D. Schein, Sunlight exposure and risk of lens opacities in a population-based study: the Salisbury Eye Evaluation project, JAMA, 1998, 280, 714-718.
20. N. Katoh, F. Jonasson, H. Sasaki, M. Kojima, M. Ono, N. Takahashi and K. Sasaki, Cortical lens opacification in Iceland. Risk factor analysis-Reykjavik Eye Study, Acta Ophthalmol. Scand., 2001, 79, 154-159.
21. S. K. West, Ocular ultraviolet B exposure and lens opacities; a review, J. Epidemiol., 1999, 9, S97-101.
22. O. Hockwin, M. Kojima, Y. Sakamoto, A. Wegener, Y. B. Shui and K. Sasaki, UV damage to the eye lens: further results from animal model studies: a review, J. Epidemiol., 1999, 9, S39-47.
23. D. G. Pitts, A. P. Cullen and P. D. Hacker, Ocular effects of ultraviolet radiation from 295 to 365 nm, Invest. Ophthalmol. Vis. Sci., 1977, 16, 932-939.
24. J. C. Merriam, S. Lofgren, R. Michael, P. Soderberg, J. Dillon, L. Zheng and M. Ayala, An action spectrum for UV-B radiation and the rat lens, Invest. Ophthalmol. Vis. Sci., 2000, 41, 2642-2647.
25. O. M. Oriowo, A. P. Cullen, B. R. Chou and J. G. Sivak, Action spectrum and recovery for in vitro UV-induced cataract usine whole lenses, Invest. Ophthalmol Vis. Sci., 2001, 42, 2596-2602.
26. J. F. Abarca, C. C. Casiccia and F. D. Zamorano, Increase in sunburns and photosensitivity disorders at the edge of the Anartic ozone hole, Southern Chile, 1986-2000, J. Am. Acad. Dermatol., 2002, 46, 193-199.
27. A. R. Young, C. A. Chadwick, G. I. Harrison, O. Nikaido, J. Ramsden and C. S. Potten, The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema, J. Invest. Dermatol., 1998, 111, 982-988.
28. R. J. Berg, H. J. Ruven, A. T. Sands, F. R. de Gruijl and L. H. Mullenders, Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J. Invest. Dermatol., 1998, 110, 405-409.
29. C. Kielbassa, L. Roza and B. Epe, Wavelength dependence of oxidative DNA damage induced by UV and visible light, Carcinogenesis, 1997, 18, 811-816.
30. F. R. de Gruijl and J. C. van der Leun, Estimate of the wavelength dependency of ultraviolet carcinogcnesis in humans and its relevance to the risk assessment of a stratospheric ozone depletion, Health Phys., 1994, 67, 319-325.
31. M. Horiguchi, K. I. Masumura, H. Ikehata, T. Ono, Y. Kanke and T. Nohmi, Molecular nature of ultraviolet B light-induced deletions in the murine epidermis, Cancer Res., 2001, 61, 3913-3918.
32. R. A. Keulers, A. R. de Roon, S. de Roode and A. D. Tates, The induction and analysis of micronuclei and cell killing by ultraviolet-B radiation in human peripheral blood lymphocytes, Photochem. Photobiol., 1998, 67, 426-432.
33. G. Emri, E. Wenczl, P. Van Erp, J. Jans, L. Roza, I. Horkay and A. A. Schothorst, Low doses of UVB or UVA induce chromosomal aberrations in cultured human skin cells, J. Invest. Dermatol., 2000, 115, 435-440.
34. C. Masutani, R. Kusumoto, A. Yamada, N. Dohmae, M. Yokoi, M. Yuasa, M. Araki, S. Iwai, K. Takio and F. Hanaoka, The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta, Nature, 1999, 399, 700-704.
35. C. L. Limoli, E. Giedzinski, W. F. Morgan and J. E. Cleaver, Inaugural article: polymerase eta deficiency in the xeroderma pigmentosum variant uncovers an overlap between the S phase checkpoint and double-strand break repair, Proc. Natl. Acad. Sci. USA, 2000, 97, 7939-7946.
36. P. Wolf, H. Maier, R. R. Mullegger, C. A. Chadwick, R. Hofmann-Wellenhof, H. P. Soyer, A. Hofer, J. Smolle, M. Horn, L. Cerroni, D. Yarosh, J. Klein, C. Bucana, K. Dunner, Jr., C. S. Potten, H. Honigsmann, H. Kerl and M. L. Kripke, Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha, J. Invest. Dermatol., 2000, 114, 149-156.
37. H. Stege, L. Roza, A. A. Vink, M. Grewe, T. Ruzicka, S. Grether-Beck and J. Krutmann, Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin, Proc. Natl. Acad. Sci. USA, 2000, 97, 1790-1795.
38. A. Hannuksela-Svahn, E. Pukkala and J. Karvonen, Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995, Arch. Dermatol., 1999, 135, 781-786.
39. M. Staples, R. Marks and G. Giles, Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs startine to have an effect?, Int. J. Cancer, 1998, 78, 144-148.
40. IARC, Solar and ultraviolet radiation, Vol. 55, International Agency for Research on Cancer, Lyon, 1992.
41. S. A. Holme, K. Malinovszky and D. L. Roberts, Changing trends in non-melanoma skin cancer in South Wales, 1988-98, Brit. J. Dermatol., 2000, 143, 1224-1229.
42. I. Plesko, G. Severi, A. Obsitnikova and P. Boyle, Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995, Neoplasma, 2000, 47, 137-142.
43. R. B. Harris, K. Griffith and T. E. Moon, Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996, J. Am. Acad. Dermatol., 2001, 45, 528-536.
44. J. Scotto, H. Pitcher and J. A. Lee, Indications of future decreasing trends in skin-melanoma mortality among whites in the United States, Int. J. Cancer, 1991, 49, 490-497.
45. R. M. MacKie, D. Hole, J. A. Hunter, R. Rankin, A. Evans, K. McLaren, M. Fallowfield, A. Hutcheon and A. Morris, Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group, Brit. Med. J., 1997, 315, 1117-1121.
46. G. G. Giles, B. K. Armstrong, R. C. Burton, M. P. Staples and V. J. Thursfield, Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994, Brit. Med. J., 1996, 312, 1121-1125.
47. G. Severi, G. G. Giles, C. Robertson, P. Boyle and P. Autier, Mortality from cutaneous melanoma: evidence for contrasting trends between populations, Brit. J. Cancer., 2000, 82, 1887-1891.
48. A. Green, G. Williams, R. Neale, V. Hart, D. Leslie, P. Parsons, G. C. Marks, P. Gaffney, D. Battistutta, C. Frost, C. Lang and A. Russell, Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial, Lancet, 1999, 354, 723-729.
49. D. Yarosh, J. Klein, A. O'Connor, J. Hawk, E. Rafal and P. Wolf, Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group, Lancet, 2001, 357, 926-929.
50. A. S. Jonason, S. Kunala, G. J. Price, R. J. Restifo, H. M. Spinelli, J. A. Persing, D. J. Leffell, R. E. Tarone and D. E. Brash, Frequent clones of p53-mutated keratinocytes in normal human skin, Proc. Natl. Acad. Sci. USA, 1996, 93, 14025-14029.
51. Z. P. Ren, F. Ponten, M. Nister and J. Ponten, Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis, Int. J. Cancer, 1996, 69, 174-179.
52. H. Rebel, L. O. Mosnier, R. J. Berg, A. Westerman-de Vries, H. van Steeg, H. J. van Kranen and F. R. de Gruijl, Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity, Cancer Res., 2001, 61, 977-983.
53. H. Hahn, C. Wicking, P. G. Zaphiropoulous, M. R. Gailani, S. Shanley, A. Chidambaram, I. Vorechovsky, E. Holmberg, A. B. Unden, S. Gillies, K. Negus, I. Smyth, C. Pressman, D. J. Leffell, B. Gerrard, A. M. Goldstein, M. Dean, R. Toftgard, G. Chenevix-Trench, B. Wainwright and A. E. Bale, Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome, Cell, 1996, 85, 841-851.
54. A. Kamb, N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day, 3rd, B. E. Johnson and M. H. Skolnick, A cell cycle regulator potentially involved in genesis of many tumor types, Science, 1994, 264, 436-440.
55. N. Dahmane, J. Lee, P. Robins, P. Heller and A. Ruiz i Altaba, Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours, Nature, 1997, 389, 876-881.
56. M. R. Gailani, M. Stahle-Backdahl, D. J. Leffell, M. Glynn, P. G. Zaphiropoulos, C. Pressman, A. B. Unden, M. Dean, D. E. Brash, A. E. Bale and R. Toftgard, The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat. Genet., 1996, 14, 78-81.
57. M. Aszterbaum, J. Epstein, A. Oro, V. Douglas, P. E. LeBoit, M. P. Scott and E. H. Epstein, Jr., Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice, Nat. Med., 1999, 5, 1285-1291.
58. M. Ruas and G. Peters, The p16INK4a/CDKN2A tumor suppressor and its relatives, Biochim. Biophys. Acta, 1998, 1378, F115-177.
59. J. O. Funk, P. I. Schiller, M. T. Barrett, D. J. Wong, P. Kind and C. A. Sander, p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma, J. Cutan. Pathol., 1998, 25, 291-296.
60. M. Serrano, H. Lee, L. Chin, C. Cordon-Cardo, D. Beach and R. A. DePinho, Role of the INK4a locus in tumor suppression and cell mortality, Cell, 1996, 85, 27-37.
61. P. Krimpenfort, K. C. Quon, W. J. Mooi, A. Loonstra and A. Berns, Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice, Nature, 2001, 413, 83-86.
62. N. E. Sharpless, N. Bardeesy, K. H. Lee, D. Carrasco, D. H. Castrillon, A. J. Aguirre, E. A. Wu, J. W, Horner and R. A. DePinho, Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis, Nature, 2001, 413, 86-91.
63. A. van Elsas, S. F. Zerp, S. van der Flier, K. M. Kruse, C. Aarnoudse, N. K. Hayward, D. J. Ruiter and P. I. Schrier, Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma, Am. J. Pathol., 1996, 149, 883-893.
64. H. Davies, G. R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teaaue, H. Wofiendin, M. J. Garnett, W. Bottomley, N. Davis, E. Dicks, R. Ewing, Y. Floyd, K. Gray, S. Hall, R. Hawes, J. Hughes, V. Kosmidou, A. Menzies, C. Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, R. Wilson, H. Jayatilake, B. A. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. J. Riggins, D. D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, J. W. Ho, S. Y. Leung, S. T. Yuen, B. L. Weber, H. F. Seigler, T. L. Darrow, H. Paterson, R. Marais, C. J. Marshall, R. Wooster, M. R. Stratton and P. A. Futreal, Mutations of the BRAF gene in human cancer, Nature, 2002, 417, 949-954.
65. F. P. Noonan, J. A. Recio, H. Takayama, P. Duray, M. R. Anver, W. L. Rush, E. C. De Fabo and G. Merlino, Neonatal sunburn and melanoma in mice. Nature, 2001, 413, 271-272.
66. F. P. Noonan, T. Otsuka, S. Bang, M. R. Anver and G. Merlino, Accelerated ultraviolet radiation-induced carcinogenests in hepatocyte growth factor/scatter factor transaenic mice, Cancer Res., 2000, 60, 3738-3743.
67. E. S. Robinson, G. B. Hubbard, G. Colon and J. L. Vandeberg, Low-dose ultraviolet exposure early in development can lead to widespread melanoma in the opossum model, Int. J. Exp. Pathol., 1998, 79, 235-244.
68. J. Chan, E. S. Robinson, J. Atencio, Z. Wang, S. Kazianis, L. D. Coletta, R. S. Nairn and J. R. McCarrey, Characterization of the CDKN2A and ARF genes in UV-induced melanocytic hyperplasias and melanomas of an opossum (Monodelphis domestica), Mol. Carcinog., 2001, 31, 16-26.
69. E. S. Robinson, R. H. Hill, Jr., M. L. Kripke and R. B. Setlow, The Monodelphis melanoma model: initial report on large ultraviolet A exposures of suckling young, Photochem. Photobiol., 2000, 71, 743-746.
70. S. Q. Wang, R. Setlow, M. Berwick, D. Polsky, A. A. Marghoob, A. W. Kopf and R. S. Bart, Ultraviolet A and melanoma: a review, J. Am. Acad. Dermatol., 2001, 44, 837-846.
71. G. J. Clydesdale, G. W. Dandie and H. K. Muller, Ultraviolet light induced injury: immunological and inflammatory effects, Immunol. Cell Biol., 2001, 79, 547-568.
72. A. M. Moodycliffe, D. Nghiem, G. Clydesdale and S. E. Ullrich, Immune suppression and skin cancer development: regulation by NKT cells, Nat. Immunol., 2000, 1, 521-525.
73. A. Schwarz, S. Beissert, K. Grosse-Heitmeyer, M. Gunzer, J. A. Bluestone, S. Grabbe and T. Schwarz, Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance, J. Immunol., 2000, 165, 1824-1831.
74. J. F. Rooney, Y. Bryson, M. L. Mannix, M. Dillon, C. R. Wohlenberg, S. Banks, C. J. Wallington, A. L. Notkins and S. E. Straus, Prevention of ultraviolet-light-induced herpes labialis by sunscreen, Lancet, 1991, 338, 1419-1422.
75. M. Gallerani and R. Manfredini, Seasonal variation in herpes zoster infection, Brit. J. Dermatol., 2000, 142, 588-589.
76. M. Zak-Prelich, J. L. Borkowski, F. Alexander and M. Norval, The role of solar ultraviolet irradiation in zoster, Epidemiol. Inf., 2002, 129, 1-5.
77. J. Breuer-McHam, E. Simpson, I. Dougherty, M. Bonkobara, K. Ariizumi, D. E. Lewis, D. B. Dawson, M. Duvic and P. D. Cruz, jr. Activation of HIV in human skin by ultraviolet B radiation and its inhibition by NFkappaB blocking agents, Photochem. Photobiol., 2001, 74, 805-810.
78. F. Termorshuizen, R. B. Geskus, M. T. Roos, R. A. Coutinho and H. Van Loveren, Seasonal influences on immunological parameters in HIV-infected homosexual men: searching for the immunomodulating effects of sunlight, Int. J. Hyg. Environ. Health, 2002, 205, 379-384.
79. R. Akaraphanth and H. W. Lim, HIV, UV and immunosuppression, photodermatol. Photoimmunol. Photomed., 1999, 15, 28-31.
80. T. A. Swartz, P. Skalska, C. G. Gerichter and W. C. Cockburn, Routine administration of oral polio vaccine in a subtropical area. Factors possibly influencing sero-conversion rates, J. Hyg. (Lond), 1972, 70, 719-726.
81. M. P. Zykov and A. V. Sosunov, Vaccination activity of live influenza vaccine in different seasons of the year, J. Hyg. Epidemiol. Microbiol. Immunol., 1987, 31, 453-459.
82. A. Sleijffers, J. Garssen, F. R. de Gruijl, G. J. Boland, J. van Hattum, W. A. van Vloten and H. van Loveren, Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers, J. Invest. Dermatol., 2001, 117, 1144-1150.
83. D. L. Damian, G. M. Halliday, C. A. Taylor and R. S. Barnetson, Ultraviolet radiation induced suppression of Mantoux reactions in humans, J. Invest. Dermatol., 1998, 110, 824-827.
84. A. J. McMichael and A. J. Hall, Does immunosuppressive ultraviolet radiation explain the latitude Gradient for multiple sclerosis?, Epidemiology, 1997, 8, 642-645.
85. D. M. Freedman, M. Dosemeci and M. C. Alavanja, Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates, Occup. Environ. Med., 2000, 57, 418-421.
86. L. Nystrom, G. Dahlquist, J. Ostman, S. Wall, H. Arnqvist, G. Blohme, F. Lithner, B. Littorin, B. Schersten and L. Wibell, Risk of developing insulin-dependent diabetes mellitus (IDDM) before 35 years of age: indications of climatological determinants for age at onset, Int. J. Epidemiol, 1992, 21, 352-358.
87. M. Rihner and H. McGrath, Jr., Fluorescent light photosensitivity in patients with systemic lupus erythematosus, Arthritis Rheum., 1992, 35, 949-952.
88. L. M. Vila, A. M. Mayor, A. H. Valentin, S. I. Rodriguez, M. L. Reyes, E. Acosta and S. Vila, Association of sunlight exposure and photoprotection measures with clinical outcome in systemic lupus erythematosus, P. R. Health Sci. J., 1999, 18, 89-94.
89. H. Van Loveren, A. Boonstra, M. Van Dijk, A. Fluitman, H. F. Savelkoul and J. Garssen, UV exposure alters respiratory allergic responses in mice, Photochem. Photobiol., 2000, 72, 253-259.
90. M. Norval, J. Garssen, H. Van Loveren and A. A. el-Ghorr, UV-induced changes in the immune response to microbial infections in human subjects and animal models, J. Epidemiol., 1999, 9, S84-92.
91. K. Yamamoto, R. Ito, M. Koura and T. Kamiyama, UV-B irradiation increases susceptibility of mice to malarial infection, Infect. Immun., 2000, 68, 2353-2355.
92. J. C. van der Leun, Y. Takizawa and J. Longstreth, in Environmental Effects Panel Report eds.: J. C. van der Leun and M. Tevini, United Nations Environmental Programme, Nairobi, 1989, pp. 11-24.
93. L. K. Ryan, D. L. Neldon, L. R. Bishop, M. I. Gilmour, M. J. Daniels, D. M. Sailstad and M. J. Selgrade, Exposure to ultraviolet radiation enhances mortality and pathology associated with influenza virus infection in mice, Photochem. Photobiol., 2000, 72, 497-507.
94. J. Garssen, R. van der Molen, A. de Klerk, M. Norval and H. van Loveren, Effects of UV irradiation on skin and nonskin-associated herpes simplex virus infections in rats, Photochem. Photobiol., 2000, 72, 645-651.
95. E. L. Brown, S. E. Ullrich, M. Pride and M. L. Kripke, The effect of UV irradiation on infection of mice with Borrelia burgdorferi, Photochem. Photobiol., 2001, 73, 537-544.
96. E. C. De Fabo, F. P. Noonan and J. E. Frederick, Biologically effective doses of sunlight for immune suppression at various latitudes and their relationship to chances in stratospheric ozone, Photochem. Photobiol., 1990, 52, 811-817.
97. J. Garssen, W. Goettsch, F. de Gruijl, W. Slob and H. van Loveren, Risk assessment of UVB effects on resistance to infectious diseases, Photochem. Photobiol., 1996, 64, 269-274.
98. D. A. Kelly, S. L. Walker, J. M. McGregor and A. R. Young, A single exposure of solar simulated radiation suppresses contact hypersensitivity responses both locally and systemically in humans: quantitative studies with hish-frequency ultrasound, J. Photochem. Photobiol. B, 1998, 44, 130-142.
99. T. Yoshikawa, V. Rae, W. Bruins-Slot, J. W. Van den Berg, J. R. Taylor and J. W. Streilein, Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans, J. Invest. Dermatol., 1990, 95, 530-536.
100. D. A. Kelly, A. R. Young, J. M. McGregor, P. T. Seed, C. S. Potten and S. L. Walker, Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity, J. Exp. Med., 2000, 191, 561-566.
101. P. H. Hart, M. A. Grimbaldeston, G. J. Swift, A. Jaksic, F. P. Noonan and J. J. Finlay-Jones, Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice, J. Exp. Med., 1998, 187, 2045-2053.
102. M. A. Grimbaldeston, L. Skov, O. Baadsgaard, B. G. Skov, G. Marshman, J. J. Finlay-Jones and P. H. Hart, Communications: high dermal mast cell prevalence is a predisposing factor for basal cell carcinoma in humans, J. Invest. Dermatol., 2000, 115, 317-320.
103. P. H. Hart, M. A. Grimbaldeston, G. J. Swift, E. K. Hosszu and J. J. Finlay-Jones, A critical role for dermal mast cells in cisurocanic acid-induced systemic suppression of contact hypersensitivity responses in mice, Photochem. Photobiol., 1999, 70, 807-812.
104. F. De Fine Olivarius, J. Lock-Andersen, F. G. Larsen, H. C. Wulf, J. Crosby and M. Norval, Urocanic acid isomers in patients with basal cell carcinoma and cutaneous malignant melanoma, Brit. J. Dermatol., 1998, 138, 986-992.
105. E. Snellman, C. T. Jansen, T. Rantanen and P. Pasanen, Epidermal urocanic acid concentration and photoisomerization reactivity in patients with cutaneous malignant melanoma or basal cell carcinoma, Acta Derm. Venereol., 1999, 79, 200-203.
106. S. Beissert, D. Ruhlemann, T. Mohammad, S. Grabbe, A. El-Ghorr, M. Norval, H. Morrison, R. D. Granstein and T. Schwarz, IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis, J. Immunol., 2001, 167, 6232-6238.
107. F. Levi, L. Randimbison, C. La Vecchia, G. Erler and V. C. Te, Incidence of invasive cancers following squamous cell skin cancer, Am. J. Epidemiol., 1997, 146, 734-739.
108. F. Levi, L. Randimbison, V. C. Te and C. La Vecchia, Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers, Brit. J. Cancer., 1996, 74, 1847-1850.
109. M. Frisch, H. Hjalgrim, J. H. Olsen and M. Melbye, Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study, Ann. Intern. Med, 1996, 125, 815-821.
110. H. Goldberg, Basal-cell carcinoma as predictor for other cancers, Lancet, 1997, 349, 664-665.
111. G. Bentham, Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales, Brit. Med. J., 1996, 312, 1128-1131.
112. A. J. McMichael and G. G. Giles, Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?, Brit. J. Cancer., 1996, 73, 945-950.
113. I. H. Langford, G. Bentham and A. L. McDonald, Mortality from non-Hodgkin lymphoma and UV exposure in the European Community, Health Place, 1998, 4, 355-364.
114. J. Adami, G. Gridley, O. Nyren, M. Dosemeci, M. Linet, B. Glimelius, A. Ekbom and S. H. Zahm, Sunlight and non-Hodgkin's lymphoma: a populalion-based cohort study in Sweden, Int. J. Cancer, 1999, 80, 641-645.
115. P. Hartge, S. S. Devesa, D. Grauman, T. R. Fears and J. F. Fraumeni, Jr., Non-Hodgkin's lymphoma and sunlight, J. Natl. Cancer. Inst., 1996, 88, 298-300.
116. L. J. Schouten, H. Meijer, J. A. Huveneers and L. A. Kiemeney, Urban-rural differences in cancer incidence in The Netherlands 1989-1991, Int. J. Epidemiol., 1996, 25, 729-736.
117. N. Hakansson, B. Floderus, P. Gustavsson, M. Feychting and N. Hallin, Occupational sunlight exposure and cancer incidence among Swedish construction workers, Epidemiology, 2001, 12, 552-557.
118. M. Nordstrom, L. Hardell, A. Magnusson, H. Hagberg and A. Rask-Andersen, Occupation and occupational exposure to UV light as risk factors for hairy cell leukaemia evaluated in a case-control study, Eur. J. Cancer. Prev., 1997, 6, 467-472.
119. G. Bentham, A. M. Wolfreys, Y. Liu, G. Cortopassi, M. H. Green, C. F. Arlett and J. Cole, Frequencies of hprt(-) mutations and bcl-2 translocations in circulating human lymphocytes are correlated with United Kingdom sunlight records, Mutagenesis, 1999, 14 527-532.
120. W. Jiang, H. N. Ananthaswamy, H. K. Muller, A. Ouhtit, S. Bolshakov, S. E. Ullrich, A. K. El-Naggar and M. L. Kripke, UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53, Proc. Natl. Acad. Sci. USA, 2001, 98, 9790-9795.
121. G. P. Studzinski and D. C. Moore, Sunlight-can it prevent as well as cause cancer?, Cancer Res., 1995, 55, 4014-4022.
122. C. L. Hanchette and G. G. Schwartz, Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation, Cancer, 1992, 70, 2861-2869.
123. C. J. Luscombe, A. A. Fryer, M. E. French, S. Liu, M. F. Saxby, P. W. Jones and R. C. Strange, Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer, Lancet, 2001, 358, 641-642.
124. J. M. Norris, Can the sunshine vitamin shed light on type 1 diabetes?, Lancet, 2001, 358, 1476-1478.
125. TEAP, UNEP Report of Technology and Economic Assessment Panel, United Nations Environmental Programme Report, Nairobi.
126. M. Kojima, T. Okuno, M. Miyakoshi, K. Sasaki and N. Takahashi, in Progress in Lens and Cataract Research, Vol. 35 eds.: O. Hockwin, M. Kojima, N. Takahashi and D. H. Sliney, Karger, Basel, 2002, pp. 125-134.
127. D. T. Shindell, D. Rind and P. Lonergan, Increased polar stratospheric ozone losses and delayed eventual recovery owing to increased greenhouse-gas concentrations, Nature, 1998, 392, 589-592.
128. H. Slaper, G. J. Velders, J. S. Daniel, F. R. de Gruijl and J. C. van der Leun, Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements, Nature, 1996, 384, 256-258.
129. G. Kelfkens, A. Bergman, F. R. de Gruijl, J. C. Van der Leun, A. Piquet, T. van Oijen, W. W. C. Gieskens, H. van Loveren, G. J. M. Velders, P. Martens and H. Slaper, Ozone and climate change interactions; Influence on UV levels and UV-related effects, National Programme on Global Air Pollution and Climate Change Report No. Bilthoven, Netherlands.
130. J. A. Bain, H. P. Rusch and B. E. Kline, The effect of temperature upon ultraviolet carcinogenesis with wavelengths 2,800-3,400 Å, Cancer Res., 1943, 3, 610-612.
131. R. G. Freeman and J. M. Knox, Influence of temperature on ultraviolet injury, Arch. Dermatol., 1964, 89, 858-864.
132. J. C. van der Leun and F. R. de Gruijl, Climate change and skin cancer, Photochem. Photobiol. Sci., 2002, 1, 324-326.
133. J. Longstreth, Anticipated public health consequences of global climate change, Environ. Health Perspect., 1991, 96, 139-144.
134. A. Leaf, Potential health effects of global climatic and environmental changes, N. Engl. J. Med., 1989, 321, 1577-1583.
135. P. R. Epstein, Global warming and vector-borne disease, Lancet, 1998, 351, 1737; discussion 1738.
136. J. Longstreth, Public health consequences of global climate change in the United States-some regions may suffer disproportionately, Environ. Health Perspect., 1999, 107(Suppl 1), 169-179.